Fentanyl and a Novel Synthetic Opioid U-47700 Masquerading as Street “Norco” in Central California: A Case Report

Annals of Emergency Medicine

Volumn 69, Issue 1, 2017, Pages 87-90

  Armenian, Patil ^a   Olson, Alexander ^b   Anaya, Andres ^a   Kurtz, Alicia ^a   Ruegner, Rawnica ^a   Gerona, Roy R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; BENZAMIDE DERIVATIVE; BENZOYLECGONINE; DIPHENHYDRAMINE; FENTANYL; GABAPENTIN; GLUCOSE; HYDROCODONE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; LORAZEPAM; MU OPIATE RECEPTOR AGONIST; NALOXONE; NARCOTIC ANALGESIC AGENT; PARACETAMOL; SERTRALINE; TRANS 3,4 DICHLORO N [2 (DIMETHYL AMINO)CYCLOHEXYL] N METHYLBENZ AMIDE; UNCLASSIFIED DRUG; DESIGNER DRUG; NARCOTIC AGENT; U-47700;

ADULT; ANALGESIA; ANXIETY DISORDER; ARTICLE; BACKACHE; BLOOD OXYGEN TENSION; BLOOD PRESSURE; BREATHING RATE; CALIFORNIA; CASE REPORT; CHRONIC PAIN; CLINICAL OBSERVATION; CONSCIOUSNESS DISORDER; CONVALESCENCE; DRUG BLOOD LEVEL; DRUG EXPOSURE; FEMALE; HOSPITAL DISCHARGE; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MENTAL DISEASE; MIOSIS; PRIORITY JOURNAL; PRURITUS; QUADRUPOLE MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; RESPIRATION DEPRESSION; SENSE OF COHERENCE; SOMNOLENCE; TIME OF FLIGHT MASS SPECTROMETRY; VITAL SIGN; COMPLICATION; DRUG INTERACTION; HOSPITAL EMERGENCY SERVICE; OPIOID-RELATED DISORDERS;

ADULT; BENZAMIDES; CALIFORNIA; DESIGNER DRUGS; DRUG INTERACTIONS; EMERGENCY SERVICE, HOSPITAL; FEMALE; FENTANYL; HUMANS; NARCOTICS; OPIOID-RELATED DISORDERS;

EID: 84996799366     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2016.06.014     Document Type: Article

References (18)

1. 1 Rudd, R.A., Aleshire, N., Zibbell, J.E., et al. Increases in drug and opioid overdose deaths—United States, 2000-2014. MMWR Morb Mortal Wkly Rep 64 (2016), 1378–1382.
2. 2 Ogilvie, L., Stanley, C., Lewis, L., et al. Acetyl fentanyl overdose fatalities—Rhode Island, March–May 2013. MMWR Morb Mortal Wkly Rep 62 (2013), 703–704.
3. 3 Centers for Disease Control & Prevention. Increases in fentanyl drug confiscations and fentanyl-related overdose fatalities. October 26, 2015. Available at: http://emergency.cdc.gov/han/han00384.asp. Accessed April 24, 2016.
4. 4 Buck, C., Sacramento County fentanyl fatalities at 12, could grow. Sacramento Bee, April 18, 2016 Available at: http://www.sacbee.com/news/local/health-and-medicine/article72531312.html Accessed April 24, 2016.
5. 5 Vo, K.T., van Wijk, X.M., Lynch, K.L., et al. Counterfeit Norco poisoning outbreak San Francisco Bay Area, California, March 25–April 5, 2016. MMWR Morb Mortal Wkly Rep 65 (2016), 420–423.
6. 6 Zalkind, S., Synthetic opiate makers stay step ahead of US drug laws as overdose cases rise. Guardian, April 11, 2016 Available at: http://www.theguardian.com/world/2016/apr/11/synthetic-opiates-drug-laws-w-18-fentanyl Accessed April 24, 2016.
7. 7 Lung, D., Wilson, N., Chatenet, F.T., et al. Non-targeted screening for novel psychoactive substances among agitated emergency department patients. Clin Toxicol 54 (2016), 319–323.
8. 8 Cheney, B.V., Szmuszkovicz, J., Lahti, R.A., et al. Factors affecting binding of trans-N-[2-(methylamino)cyclohexyl] benzamides at the primary morphine receptor. J Med Chem 28 (1985), 1853–1864.
9. 9 Spargo, E.A., Two fatalities involving the use of the synthetic opioid U-47700. Toxtalk 40 (2016), 9–15.
10. 10 Lotsch, J., Walter, C., Parnham, M.J., et al. Pharmacokinetics of non-intravenous formulations of fentanyl. Clin Pharmacokinet 52 (2013), 23–36.
11. 11 Takahashi, M., Sugiyama, K., Hori, M., et al. Naloxone reversal of opioid anesthesia revisited: clinical evaluation and plasma concentration analysis of continuous naloxone infusion after anesthesia with high-dose fentanyl. J Anesth 18 (2004), 1–8.
12. 12 Helander, A., Backberg, M., Beck, O., Intoxications involving the fentanyl analogs acetylfentanyl, 4-methoxybutyrfentanyl and furanylfentanyl: results from the Swedish STRIDA project. Clin Toxicol (Phila) 54 (2016), 324–332.
13. 13 Drug Enforcement Administration; Department of Justice. Schedules of controlled substances: placement of AH-7921 into schedule I. Final order. Fed Reg 81 (2016), 22023–22025.
14. 14 North Carolina Department of Health and Human Services. 19 Recent deaths associated with synthetic opioids; state officials urge awareness. March 24, 2016. Available at: http://www.ncdhhs.gov/news/press-releases/19-recent-deaths-associated-synthetic-opioids-state-officials-urge-awareness. Accessed April 24, 2016.
15. 15 Trends.google.com. Available at: https://www.google.com/trends/explore#q=u-47700%2C%20ah-7921&date=1%2F2004%20148m&cmpt=q&tz=Etc%2FGMT%2B7. Accessed April 24, 2016.
16. 16 Ching Labs U47700 powder. Available at: http://chinglabs.com/sedatives/. Accessed April 24, 2016.
17. 17 Uges DRA. TIAFT reference blood level list of therapeutic and toxic substances. September 2004. Available at: https://www.yumpu.com/en/document/view/13423269/quottiaft-reference-blood-level-list-of-therapeutic-and-toxic-gtfch. Accessed April 26, 2016.
18. 18 Schulz, M., Iwersen-Bergmann, S., Andresen, H., et al. Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care, 16, 2012, R136.